Severe acute respiratory syndrome (SARS). Lesson and challenges;Síndrome respiratorio agudo severo (SRAS). Lecciones y retos

Investigacion Clinica

Volumn 46, Issue 1, 2005, Pages 75-95

  Valero, Nereida ^a   Larreal, Yraima ^a   Masquera, Jesús ^a   Rincón, Enrique ^b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Hospital Noriega Trigo   (Venezuela)

Author keywords

Coronavirus Atypical pneumonia; SARS diagnosis; Severe Acute Respiratory Syndrome; SRAS

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; IMMUNOGLOBULIN M; LOPINAVIR; MACROLIDE; OSELTAMIVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITONAVIR; SALBUTAMOL;

ASIA; CORONAVIRUS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EPIDEMIC; HUMAN; INTERNATIONAL COOPERATION; MORBIDITY; OPPORTUNISTIC INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SYSTEMATIC REVIEW; VIRUS GENOME; VIRUS PNEUMONIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEVERE ACUTE RESPIRATORY SYNDROME; SEX FACTORS;

EID: 16244365176     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Lleras A. Síndrome Respiratorio Agudo Severe ¿Una Pandemia?. Kasmera 2002; 31(1):5-6.
2. World Health Organization. Cumulative number of reported cases of Severe Acute Respiratory Syndrome (SRAS) Geneva: 2003. Available from: http/www.who.int/ crs/SRAScountry.
3. Geberding J. Faster but Fast Enough? Respending to the Epidemic of Severe Acute Respiratory Syndrome. N Engl J Med 2003; 348(20):2030-2031.
4. World Health Organization. Suspected SRAS case still under close watch. Available from:http// www.info.gov.hk/info/ SRAS/eindex.htm.
5. Poutanem SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Avers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, Mcgeer AJ, and members of the National Microbiology Laboratory, Canada, and the Canadian Severe Acute Respiratory Syndrome Study. Identification of Severe Acute Respiratory Syndrome in Canada. N Eng J Med 2003; 348 (20):1995-2005.
6. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Wilhelm H. Identification of a novel Coronavirus in patients with Severe Acute Respiratory Syndrome. N Engl J Med 2003; 348(20): 1967-1976.
7. Majarrez MA. Virus Influenza: Enigmas del pasado y del presente. Rev Inst Nal Enf Resp Mex 1999; 12(4):290-299.
8. Falsey AR, Erdman D, Anderson LJ, Wals EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003; 87:785-790.
9. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer J, Lim W, Rollin P, Dowel SF, Ling A, Humphrey CD, Shieh W, Guarner J, Paddock C, Rota P, Fields B, DeRisi J, Yang J, Cox N, Hughes J, LeDuc J, Bellini W, Anderson L, and members of the SRAS working group. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N Engl J Med 2003; 348(20):1953-1965.
10. Peret TC, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus AD, Erdmann DD, Anderson LJ. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis 2002; 185:1660-1663.
11. Nissen MD, Siebert DJ, Mackay IM, Sloots TP, Withers SJ. Evidence of human metapneumovirus in Australian children. Med J Aust 2002; 176(4):188.
12. Zhang Q, Cui J, Huang X, Lin W, Tan D, Xu J, Yang Y, Zhang J, Zhang X, Li H, Zheng H, Chen Q, Yan X, Zheng K, Wan Z, Huang J. Morphology and Morphogenesis of Severe Acute Respiratory Syndrome (SRAS)-associated Virus. J Pathol 2003; 200:282-289.
13. Organización Mundial de la Salud. Confimado en el laboratorio el caso de SRAS en el Sur de China. Available from: http// www.who.int/csr/don/ 2004_01_05/es/.
14. Holmes KV. Coronaviridae and their replication. Virology. Fields BN, Knipe D. Raven Press, New York; 1996, p 841-856.
15. Seto WH, Tsang D, Yung RW, Ching TY, Ng TK, Ho M, Ho LM, Peiris JS. Advisors of Expert SRAS group of Hospital Authority. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of Severe Acute Respiratory Syndrome (SRAS). Lancet 2003; 361(9368):1519-1520.
16. Cheng VC, Hung IF, Tang BS, Chu CM, Wong MM, Chan KH, Wu AK, Tse DM, Chan KS, Zheng BJ, Peiris JS, Sung JJ, Yuen KY. Viral replication in the nasopharynx is associated with diarrhea in patients with Severe Acute Respiratory Syndrome. Clin Infect Dis 2004; 38(4): 467-475.
17. Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, Yuen KY, Sung JJ. Enteric involvement of Severe Acute Respiratory Syndrome-associated coronavirus infection. Gastroenterology 2003; 125(4): 1011-1017.
18. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY; and SRAS study group. Coronavirus as posible cause of Acute Severe Respiratory Syndrome. Lancet 2003; 361:1312-1313.
19. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt G, Ahuna A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJ. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong. N Engl J Med 2003; 348:1986-1994.
20. World Health Organization. Case definitions for surveillance of Severe Acute Respiratory Syndrome (SRAS). Geneva: 2003. Available from: http://www.who.int/csr/ SRAS/casedefinition).
21. Centers for Disease Control and Prevention. Severe Acute Respiratory Syndrome (SRAS). Atlanta: 2003. Available from:http://www.cdc.gov/ncidod/SRAS/.
22. Preliminary Clinical Description of Severe Acute Respiratory Syndrome. MMWR 2003; 52:255-256.
23. World Health Organization Weekly epidemiological record. 78(12):81-88. Available from: http://www.who.int/wer/pdf/2003/ wer7812.
24. Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, Li AM, Fong NC, Ng PC, Chiu MC, Li CK, Tam JS, Fok TF. Clinical presentation and outcome of Severe Acute Respiratory Syndrome in children. Lancet 2003; 361:1701-1703.
25. Falsey AR, Walsh EE. Novel coronavirus and Severe Acute Respiratory Syndrome. Lancet 2003; 361(9366):1312-1313.
26. Tsang K, Ho P, Ooi G, Yee W, Wang T, Chan M, Lam W, Seto W, Yam L, Cheung T, Wong P, Lam B, Ip M, Chan J, Yuen K, Lai K. A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong. N Engl J Med 2003; 348(20):1977-1985.
27. Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, Choi KW, Tso YK, Lau T, Lai ST, Lai CL. SRAS-associated viral hepatitis caused by a novel coronavirus: Report of three cases. Hepatology 2004; 39:302-310.
28. Zhong YF, Gao XM, Wang SL, Xie ZG, Ma Y, Fang WG, Zou WZ, Li XL, Zhang QY, Wang W, Zhao ZD, Gu J. Pathologic study of circulating blood leukocytes in Severe Acute Respiratory Syndrome. Zhonghua Yi Xue Za Zhi 2003; 83:2137-2141.
29. Nicolaou S, Al-Nakshabandi N, Müller N. Radiologic Manifestations of Severe Acute Respiratory Syndrome. N Engl J Med 2003; 348(20):2006.
30. Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, Pohlmann S. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 2004; 78: 6134-6142.
31. Sylvester-Hvid C, Nielsen M, Lamberth K, Roder G, Justesen S, Lundegaard C, Worning P, Thomadsen H, Lund O, Brunak S, Buus S. SRAS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens. 2004; 63(5):395-400.
32. + T-cell epitope SSp-1 of SRAS-CoV spike protein. Blood 2003; 11:4072-4075.
33. Ching Chong KY, lion CC, Hi Hui RK, Yeung Wong RT, Yip CH, Zeng F, Ching Leung CC. Molecular advances in severe acute respiratory syndrome-associated coronavirus (SRAS-CoV). Geno Prot.& Bioinfo 2003; 1:247-262.
34. Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SRAS virus receptor. Trends Pharmacol Sci 2004; 25:291-294.
35. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, Van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SRAS coronavirus. A first step in understanding SRAS pathogenesis. J Pathol 2004; 203:631-637.
36. Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Rang W, Weng D, Liang P, Jiang S. Organ distribution of severe acute respiratory syndrome (SRAS) associated coronavirus (SRAS-CoV) in SRAS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203:622-630.
37. Chow KC, Hsiao CH, Lin TY, Chen CI, Chiou SH. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am J Clin Pathol 2004; 121:574-580.
38. Nicholls JM, Poon LL, Lee KC. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361:1773-1778.
39. Yan H, Xiao G, Zhang J, Hu Y, Yuan F, Cole DK, Zheng C, Gao GF. SRAS coronavirus induces apoptosis in Vero E6 Cells. J Med Virol 2004; 73:323-331.
40. Julkunen I, Sareneva T, Pirhonen J. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12:171-180.
41. Wong CK, Lam CWK, Wu AKL, Ip WK, Lee NLS, Chan IHS, Lit LCW, Hui DSC, Chan MHM, Cheng SSC, Spng JJY. Plasma inflammatoty cytokines ans chemokines in severe acute respiratory sindrome. Clin Exp Immunol 2004; 136:95-103.
42. Miyazaki Y, Araki K, Vesin C. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 1995; 96:250-259.
43. Wang D, Lu J. Glycan arrays lead to the discovery of auto-immunogenic activity of SRAS-CoV. Physiol Genomics 2004; 18:245-248.
44. Wang YD, Sin WY, Xu GB, Yang HH, Wong TY, Pang XW, He XY, Zhang HG, Ng JN, Cheng CS, Yu J, Meng L, Yang RF, Lai ST, Guo ZH, Xie Y. T-cell epitopes in severe acute respiratory syndrome (SRAS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SRAS. J Virol 2004; 78:5612-5618.
45. He ZP, Dong QM, Zhuang H, Song SJ, Liu ZY, Feng X. Dynamics of peripheral blood lymphocytes and their subpopulations in patients with severe acute respiratory syndrome. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25:124-126.
46. Wang D, Lu J. The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome. Am J Clin Pathol 2004; 121:507-511.
47. Zhang QL, Ding YQ, He L, Wang W, Zhang JH, Wang HJ, Cai JJ, Geng J, Lu YD, Luo YL. Detection of cell apoptosis in the pathological tissues of patients with SRAS and its significance. Di Yi Jun Yi Da Xue Xue Bao 2003; 23:770-773.
48. Ng ML, Tan SH, See EE, Ooi EE, Ling AE. Early events of SRAS coronavirus infection in vero cells. J Med Virol 2003; 71:323-331.
49. Ng ML, Tan SH, See EE, Ooi EE, Ling AE. Proliferative growth of SRAS coronavirus in Vero E6 cells. J Gen Virol 2003; 84: 3291-3303.
50. Garoff H, Hewson R, Opstelten DJE. Virus maturation by budding. Microbiol Mol Biol Rev 1998; 62:1171-1190.
51. Fields BN, Knipe DM, Howley PM, Griffin DE. Fields Virology, 4th ed. Williams Lippincott & Wilkins:Philadelphia; 2001.
52. Lai RQ, Feng XD, Wang ZC, Lai HW, Tian Y, Zhang W, Yang CH. Pathological and ultramicrostructural changes of tissues in a patient with Severe Acute Respiratory Syndrome. Zhonghua Bing Li Xue Za Zhi 2003; 32:205-208.
53. Ding YQ, Wang HJ, Shen H, Li ZG, Geng J, Han HX, Cai JJ, Li X, Rang W, Weng DS, Lu YD, Yao KT. Study on etiology and pathology of Severe Acute Respiratory Syndrome. Zhonghua Bing Li Xue Za Zhi 2003; 32:195-200.
54. He L, Ding YQ, Che XY, Zhang QL, Huang ZX, Wang HJ, Shen H, Li ZG, Cai JJ, Zhang JH, Geng J, Li X, Zhang WL, Han HX, Rang W, Yang L, Lu YD. Expression of the monoclonal antibody against nucleocapsid antigen of SRAS-associated coronavirus in autopsy tissues from SRAS patients. Di Yi Jun Yi Da Xue Xue Bao 2003; 23(11):1128-1130.
55. Wang CE, Li YC, Wu XH, Cao JT, Yan G, Li JF, Si BY, Yu M, Qin ED, Zhu QY. Ultrastructural characteristics of SRAS associated virus in infected cells. Zhonghua Bing Li Xue Za Zhi 2003; 32:209-211.
56. Ho W, Hong Kong Hospital Authority Working Group on SRAS. Guideline on management of severe acute respiratory syndrome. Lancet 2003; 361:1313-1315.
57. Charles M. Severe Acute Respiratory Syndrome (SRAS) and Coronavirus Testing. MMWR 2003; 52(14):297-302.
58. Pujol F. Un nuevo Coronavirus es el causante de la neumonía atípica, Available from: http://caibco.ucv.ve/vitae/VitaeNueve/homevitae. htm.
59. Van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7(6):719-724.
60. Ruan YJ, Wei CL, Ee AL, Vega VB, Thoreau H, Su ST, Chia JM, Ng P, Chiu KP, Lim L, Zhang T, Peng CK, Lin EO, Lee NM, Yee SL, Ng LF, Chee RE, Stanton LW, Long PM, Liu ET. Comparative full-length genome sequence análisis of 14 SRAS coronavirus isolated and common mutations associated with putative origins of infection. Lancet 2003; 361 (9371):1779-1785.
61. Mcintosh K, Kapikian AZ, Hardison KA, Hartley JAV, Chanock RM. Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol 1969; 102: 1109-1118.
62. Holmes K. SRAS-Associated Coronavirus. N Engl J Med 2003; 348(20):1948-1951.
63. Ni AP, Wang Z, Liu Y, Liu SD, Han YH, Shen Y, Qiang BQ. Isolation and identification of SRAS-coronavirus in nasal and throat swabs collected from clinically diagnosed SRAS patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003; 25:520-524.
64. University of Leicester. "Diagrama del genoma de un coronavirus". Coronavirus. Available from:〈http://www.micro.msb.le.ac. uk/ 3035/Coronaviruses.html〉.
65. Arizona State University. "Modelo de la estructura de un coronavirus" Coronavirus. Available from: 〈http:// lsvl.la.asu .edu/ubep2003/participants/ blount/〉.
66. Russell Kightley Media. "Replicación de los coronavirus". Imágenes de ciencia. Available from 〈http://www.rkm.com.au/ VIRUS/CORONAVIRUS/coronavirus-replication. html〉.
67. Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, Cai J, Li X, Rang W, Weng D, Lu Y, Wu D, He L, Yao K. The clinical pathology of Severe Acute Respiratory Syndrome (SRAS): a report from China. J Pathol 2003; 200:282-289.
68. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, Van Amerongen G, Van Riel D, Laman JD, De Jong T, Van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, Van Der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD. Newly discovered coronavirus as the primary cause of Severe Acute Respiratory Syndrome. Lancet 2003; 362:263-270.
69. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY. Role of lopinavir/ritonavir in the treatment of SRAS: initial virological and clinical findings. Thorax 2004; 59(3):252-256.
70. Ho W, Hong Kong Hospital Authority Working Group on SRAS, Central Committee of Infection Control. Guideline on management of Severe Acute Respiratory Syndrome (SRAS). Lancet 2003; 361: 1313-1315.
71. Boletín Epidemiológico semanal del IPK. Crean Científicos Canadienses tres prototipos de vacunas contra SRAS. 2003; 13(49):1-3.
72. Reilley B, Van M, Sermand D, Dentico N. SRAS and Carlo Urbani. N Engl J Med 2003; 348(20):1951-1952.